期刊文献+

脂蛋白相关磷脂酶A2及其与冠心病相关性的研究进展 被引量:2

在线阅读 下载PDF
导出
出处 《检验医学》 CAS 北大核心 2010年第9期740-743,共4页 Laboratory Medicine
作者简介 作者简介:马明坤,女,1979年生,学士,主管技师,主要从事免疫学和微生物学工作。
  • 相关文献

参考文献16

  • 1Lerman A,McConnell JP.Lipoprotein-associated pho-spholipase A2:a risk marker or a risk factor[J].Am J Cardiol,2008,101(12A):11F-22F.
  • 2刘建辉,张春妮.脂蛋白相关磷脂酶A2与动脉粥样硬化的关系[J].中国动脉硬化杂志,2008,16(7):569-571. 被引量:14
  • 3张鹭,张浩.磷脂酶A2及其功能概述[J].齐齐哈尔医学院学报,2004,25(2):178-180. 被引量:15
  • 4Zalewski A,Nelson JJ,Hegg L,et al.LP-PLA2:a new kid on the block[J].Clin Chem,2006,52(9):1645-1650.
  • 5Brilakis ES,Khera A,McGuire DK,et al.Influence of race and sex on lipoprotein-associated phospholipase A2 levels:observations from the Dallas heart study[J].Atherosclerosis,2008,199(1):110-115.
  • 6M(o)ckel M,Müller R,Vollert JO,et al.Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome:a multi-marker approach:the north Wuerttemberg and Berlin infarction study-Ⅱ (NOBIS-Ⅱ)[J].Clin Res Cardiol,2007,96(9):604-612.
  • 7O′Donoghue M,Morrow DA,Sabatine MS,et al.Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction) trial[J].Circulation,2006,113(14):1745-1752.
  • 8Vickers KC,Maguire CT,Wolfert R,et al.Rela-tionship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis[J].J Lipid Res,2009,50(9):1735-1743.
  • 9刘军妮,徐冬玲,杜贻萌,姚桂华,蒋卫东,赵敬杰,董兆强,隋树建,王欣,鹿庆华.血清脂蛋白相关磷脂酶A_2与冠状动脉粥样硬化斑块稳定性的相关研究——附107例报告[J].新医学,2009,40(1):18-20. 被引量:18
  • 10Raichlin E,McConnell JP,Bae JH,et al.Lipoprotein-associated phospholipase A2 predicts progression of cardiac allograft vasculopathy and increased risk of cardiovascular events in heart transplant patients[J].Transplantation,2008,85(7):963-968.

二级参考文献60

  • 1梁茜,董吁钢,杨希立,杨光,崔金环.血管紧张素转换酶、内皮型一氧化氮合酶和载脂蛋白E基因多态性与冠心病的相关性[J].中山大学学报(医学科学版),2006,27(4):396-400. 被引量:7
  • 2刘松.-[J].国外医学:呼吸系统分册,1997,17(3):128-130.
  • 3CORSETTI J P, RAINWATER D L, MOSS A J, et al. High lipoprotein-associated phospholipase A2 is a risk factor for recurrent coronary events in postinfarction patients [J]. ClinChem, 2006, 52 (7): 1331-1338.
  • 4BRILAKIS E S, MCCONNELL J P, LENNON R J, et al. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up[J]. Eur Heart J, 2005, 26 (2) : 137-144.
  • 5陶文惠 黄文增.冠状动脉粥样硬化性心脏病30例的血清胆红素检测分析.新医学,1999,30(6):332-332.
  • 6NAGHAVI M, LIBBY P, FALK E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part Ⅰ [ J ]. Circulation, 2003, 108 (14) : 1664-1672.
  • 7MINTZ G S, NISSEN S E, ANDERSON W D, et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (ivus). A report of the american college of cardiology task force on clinical expert consensus documents developed in collaboration with the european society of cardiology endorsed by the society of cardiac angiography and interventions [ J ]. J Am Coll Cardiol, 2001, 37 (5) : 1478-1492.
  • 8DE KORTE C L, SIEREVOGEL M J, MASTIK F, et al. Identification of atherosclerotic plaque components with intravascular ultrasound elastography in vivo: a Yucatan pig study[J]. Circulation, 2002, 105(14): 1627-1630.
  • 9BALLANTYNE C M, HOOGEVEEN R C, BANG H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study [ J ]. Circulation, 2004, 109 (7): 837-842.
  • 10Keiji Tabuchi,Zenya Ito,Shigeki Tsuji,Tetsuro Wada,Kazuhiko Takahashi,Akira Hara,Tetsuro Wada,KazuhikoTakahashi,Akira Hara,Jun Kusakari. The contribution of phospholipase A2 to the cochlear dysfunction induced by transient ischemia[J]. Hearing Research,20

共引文献44

同被引文献26

  • 1姚祖培,陈建新,陶玉华.化瘀复元胶囊治疗脑动脉硬化症36例的临床观察[J].中西医结合心脑血管病杂志,2005,3(11):951-952. 被引量:1
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2165
  • 3Ross R. Atherosclerosis: an inflammatory disease [ J]. N Engl J Med,1999,340(2) :115 -126.
  • 4Armstrong EJ,Morrow DA,Sabatine MS. Inflammatory biomarkers in a-cute coronary syndromes : part II : acute - phase reactants and biomark-ers ofendothelial cell activation. Circulation ,2006,113(8) : 152 -155.
  • 5Li JJ,Fang CH. C - reactive protein is not only an inflammatory maker-but also a direct cause of cardiovascular diseases. Medicalhypotheses,2004,62:499-506.
  • 6Ishikawa T,Imamura T,Hatakeyama K,Date H,Nagoshi T, KawamotoR,Matsuyama A,Asada Y,Eto T. Possible contribution of C - reactive-protein within coronary plaque to increasing its own plasma ievelsacrosscoronary circulation. The American Journal of cardiology,2004,93 :611-614.
  • 7Oei HH, van der Meer IM, Hofman A,et al. Lipoprotein - associated-phospholipase A2 activity is associated with risk of coronary heartdis-ease and ischemic stroke : the Rotterdam Study. Circulation,2005,111:570 -575.
  • 8Corson MA,Jones PH, Davidson MH. Review of the evidence for the-Clinical utility of lipoprotein - associated phospholipase A2 as acardio-vascular risk marker. Am J Cardiol,2008,101 :41F -51F.
  • 9Garza CA, Montori VM, McConnell JP,et al. Association betweenLi-poprotein associated phosphorlipase A2 and cardiovasculardisease : asystematic review. Mayo Clin Proceedings ,2007 ,82 : 159 - 165.
  • 10周端,童存存,褛丹飞.冠心病辨治经验[J].2011年中华中医药学会心病分会学术年会暨北京中医药学会心血管病专业委员会年会,2011:102-104.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部